AllNewsPhotosVideos
Serum Institute of India

Serum Institute Of India Private Ltd.

Serum institute of india private ltd., Latest News

Serum Institute of India is an Indian biotechnology and biopharmaceuticals company. It is the world's largest vaccine manufacturer. It is located in the city of Pune, Maharashtra, India, and was founded by Cyrus Poonawalla in 1966. The company is a subsidiary of the holding company Poonawalla Investment and Industries.
Read More
Slashed COVID-19 vaccine Covishield's prices to ensure more accessibility, reach, says SII's Adar Poonawalla - Hindi News | Slashed COVID-19 vaccine Covishield's prices to ensure more accessibility, reach, says SII's Adar Poonawalla | Latest national News at Lokmatnews.in

National :Slashed COVID-19 vaccine Covishield's prices to ensure more accessibility, reach, says SII's Adar Poonawalla

The decision to slash the prices of the precautionary dose of the COVID-19 vaccine Covishield, which is now available for all adults, was taken to make it more affordable, accessible and within reach of the masses, Chief Executive Officer (CEO) of Se ...

COVID vaccine: Covishield's price reduced from Rs 600 to Rs 225 per dose at pvt hospitals - Hindi News | COVID vaccine: Covishield's price reduced from Rs 600 to Rs 225 per dose at pvt hospitals | Latest national News at Lokmatnews.in

National :COVID vaccine: Covishield's price reduced from Rs 600 to Rs 225 per dose at pvt hospitals

Pune-based Serum Institute of India (SII) on Saturday announced that it has revised the price of its COVID vaccine Covishield for private hospitals from Rs 600 to Rs 225 per dose. ...

Covishield vaccine prices slashed for private hospitals - Hindi News | Covishield vaccine prices slashed for private hospitals | Latest health News at Lokmatnews.in

Health :Covishield vaccine prices slashed for private hospitals

New Delhi, April 9 Ahead of the opening of the booster drive for all the 18 plus range, ... ...

NTAGI to review data of SII's COVID-19 vaccine Covovax on Friday: Sources - Hindi News | NTAGI to review data of SII's COVID-19 vaccine Covovax on Friday: Sources | Latest national News at Lokmatnews.in

National :NTAGI to review data of SII's COVID-19 vaccine Covovax on Friday: Sources

The COVID-19 working group of the National Technical Advisory on Immunisation (NTAGI) will be reviewing the data of Serum Institute of India's vaccine -- Covovax for use for children and adults, on April 1, sources informed on Wednesday. ...

Novovax' COVID-19 vaccine gets emergency use authorisation for adolescents between 12-18 yrs in India - Hindi News | Novovax' COVID-19 vaccine gets emergency use authorisation for adolescents between 12-18 yrs in India | Latest international News at Lokmatnews.in

International :Novovax' COVID-19 vaccine gets emergency use authorisation for adolescents between 12-18 yrs in India

Novavax on Tuesday announced the first emergency use authorization of its COVID-19 vaccine for adolescents falling in the age bracket of 12-18 years in India. ...

DCGI grants emergency use authorisation to SII's COVID-19 vaccine Covovax for children aged above 12 years - Hindi News | DCGI grants emergency use authorisation to SII's COVID-19 vaccine Covovax for children aged above 12 years | Latest national News at Lokmatnews.in

National :DCGI grants emergency use authorisation to SII's COVID-19 vaccine Covovax for children aged above 12 years

The Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation (EUA) to Serum Institute of India's (SII) COVID-19 vaccine Covovax for adults and for children above the age of 12 years. ...

Yet another milestone in fight against COVID-19: Adar Poonawalla on Covovax getting WHO's approval - Hindi News | Yet another milestone in fight against COVID-19: Adar Poonawalla on Covovax getting WHO's approval | Latest international News at Lokmatnews.in

International :Yet another milestone in fight against COVID-19: Adar Poonawalla on Covovax getting WHO's approval

After the Covovax vaccine got WHO's approval for emergency use, Chief Executive Officer of the Serum Institute of India Adar Poonawalla on Friday said that this is yet another milestone in our fight against COVID-19. ...

Serum Institute's executive director Suresh Jadhav passes away - Hindi News | Serum Institute's executive director Suresh Jadhav passes away | Latest national News at Lokmatnews.in

National :Serum Institute's executive director Suresh Jadhav passes away

Serum Institute of India (SII) executive director Suresh Jadhav, who played an instrumental role in the field of vaccine manufacturing in India, passed away on Wednesday. ...